Jonathan Yap to Treatment Outcome
This is a "connection" page, showing publications Jonathan Yap has written about Treatment Outcome.
Connection Strength
0.809
-
Fong KY, Koh JMY, Saw LW, Anggreni D, Ng EZX, Chan YH, Poon K, Stub D, Sung SH, Chandavimol M, Lee MK, Chui ASF, Gopalamurugan AB, Nair R, Guo Y, Amanullah MR, Chao VTT, Ewe SH, Ho KW, Yap J. Clinical Outcomes of Transcatheter Mitral Valve-In-Valve and Valve-In-Ring Implantation: A Systematic Review and Meta-Analysis. Catheter Cardiovasc Interv. 2025 01; 105(1):219-238.
Score: 0.163
-
Yap J, Rogers JH, Aman E, Smith TWR, Singh GD. MitraClip Implantation Guided by Volumetric Intracardiac Echocardiography: Technique and Feasibility in Patients Intolerant to Transesophageal Echocardiography. Cardiovasc Revasc Med. 2021 07; 28S:85-88.
Score: 0.125
-
Yap J, Chen S, Smith TWR, Rogers JH, Singh GD. Transjugular mitral valve repair with the MitraClip: A step-by-step guide. Catheter Cardiovasc Interv. 2020 09 01; 96(3):699-705.
Score: 0.118
-
Yap J, Singh GD, Kim JS, Soni K, Chua K, Neo A, Koh CH, Armstrong EJ, Waldo SW, Shunk KA, Low RI, Hong MK, Jang Y, Yeo KK. Outcomes of primary percutaneous coronary intervention in acute myocardial infarction due to unprotected left main thrombosis: The Asia-Pacific Left Main ST-Elevation Registry (ASTER). J Interv Cardiol. 2018 Apr; 31(2):129-135.
Score: 0.100
-
Yap J, Tan JL, Le TT, Gao F, Zhong L, Liew R, Tan SY, Tan RS. Assessment of left ventricular preload by cardiac magnetic resonance imaging predicts exercise capacity in adult operated tetralogy of Fallot: a retrospective study. BMC Cardiovasc Disord. 2014 Sep 23; 14:122.
Score: 0.081
-
Fong KY, Ong JHW, Chan YH, Yap J, Ho KW, Aslim EJ, Ng LG, Gan VHL, Lim EJ. A Systematic Review and Meta-Analysis of Transcatheter Versus Surgical Aortic Valve Replacement in Kidney Transplant Patients. Am J Cardiol. 2023 10 01; 204:22-25.
Score: 0.037
-
Fong KY, Yap JJL, Chan YH, Ewe SH, Chao VTT, Amanullah MR, Govindasamy SP, Aziz ZA, Tan VH, Ho KW. Network Meta-Analysis Comparing Transcatheter, Minimally Invasive, and Conventional Surgical Aortic Valve Replacement. Am J Cardiol. 2023 05 15; 195:45-56.
Score: 0.036
-
Wong MYZ, Yap JJL, Chih HJ, Yan BPY, Fong AYY, Beltrame JF, Wijaya IP, Nguyen HTT, Brennan AL, Reid CM, Yeo KK. Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration. Int J Cardiol. 2023 Jan 15; 371:84-91.
Score: 0.035
-
Chiou A, Yap J, Russo S, Stripe BR, Wong GB, Southard JA. Understanding repeat hospitalizations in intermediate-to-high risk aortic stenosis patients following transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2022 03; 99(4):1188-1196.
Score: 0.033
-
Lim Y, Gochuico CFS, D'Ascenzo F, Ho KW, Lin MS, Gil IJN, Ielasi A, Tespili M, Mej?a AC, DePaoli A, Yap J, Kao HL, Lee MK, Tay E. Assessing the Impact of Transcatheter Aortic Valve Implantation on Cardiac Catheterisation: A Multicentric Study. Heart Lung Circ. 2021 Sep; 30(9):1397-1405.
Score: 0.032
-
Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, Wander GS, Yap JJ, MacDonald MR, Xu CF, Chia YM, Shimizu W, Richards AM, Voors A, Lam CS. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. Lancet Glob Health. 2018 09; 6(9):e1008-e1018.
Score: 0.026
-
Tay E, Muda N, Yap J, Muller DW, Santoso T, Walters DL, Liu X, Yamen E, Jansz P, Yip J, Zambahari R, Passage J, Ding ZP, Wang J, Scalia G, Soesanto AM, Yeo KK. The MitraClip Asia-Pacific registry: Differences in outcomes between functional and degenerative mitral regurgitation. Catheter Cardiovasc Interv. 2016 Jun; 87(7):E275-81.
Score: 0.022